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The induction of transmission-blocking immunity as a potential tool in malaria 
control was first reported in  1976 by Gwadz (1) and Carter and Chen (2) for the 
avian  malaria  parasite  Plasmodium gallinaceum.  Subsequent  reports  confirmed 
that  the  immunogens  were  present  on  the  surface  of both  male  and  female 
gametes (3,  4).  Similar  results were reported  for a  simian  malaria  parasite,  P. 
knowlesi (5), and the murine P. yoelii (6).  This work was extended to the midgut 
stages of P. gaUinaceum by Kaushal and coworkers (7-10). Since the introduction 
of the in  vitro culture for P. falciparum (I 1), good progress has been made ill 
biochemistry and molecular biology of the asexual parasites. The sexual stages, 
however, demanded special culture conditions.  The availability of gametocytes 
and gametes as well as the establishment of routine in vitro infection of mosqui- 
toes (12) were basic for further studies on this human malarial parasite.  In  1983 
Rener  et al.  (13)  demonstrated  that  monoclonal  antibodies  (mAb) 1 against  P. 
falciparum  gametes  could  interfere  with  the  transmission  of this  parasite  to 
mosquitoes. 
We here present results of experiments regarding  the nature  of antigens  on 
the  sexual  stages  of P. falciparum,  and  their  involvement  in  the  blocking  of 
transmission  by monoclonal  and  polyclonal antibodies.  These  antigens  are  se- 
quentially expressed in gametocytes, on the surface of gametes, or on ookinetes. 
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Materials  and  Methods 
Parasites.  Mature  gametocytes of P. falciparum  (isolate  NF54,  Amsterdam  Airport 
strain)  were produced in static cultures (the  "tipper"  system,  14) as well as in the large 
scale suspension  culture  system (15).  Parasite  suspensions  containing gametocytes were 
harvested  14 d  after the initiation  of the  cultures  and centrifuged at  560 g  for 5  min. 
After removal of the supernatant,  10 vol of fetal calf serum (FCS) was added to the pellet 
and allowed to stand for 30 min at room temperature to allow exflagellation to occur and 
permit the emergence of the macrogametes.  These were then  purified using a  method 
modified from Vermeulen et al. (16) (see below). 
Transmission Blocking Assays.  14-d-old cultures  from the  "tipper"  system containing 
fertile gametocytes were used. After removing the spent medium, we washed the residual 
contents of three  culture flasks (4.5  ml) containing ~1  ml of parasitized  red cells.  This 
was done by dividing the parasitized cells into two warmed tubes containing 0.5 ml packed 
red cells,  each overlaid by 3  ml  RPMI  1640 culture  medium  without serum.  The two 
tubes were centrifuged at 560 g for 2 rain.  After discarding the supernatant,  the pellets 
from the two tubes were withdrawn into a prewarmed dosing syringe containing 2 ml of 
fresh red cells suspended in 3 ml FCS. Before use, the FCS had been stored at -20°C for 
prolonged periods of time. Very little or no complement activity would have been present 
in the  FCS,  after such storage.  However,  to make  sure no active complement was still 
available,  the  FCS  was  inactivated  before  use  in  some earlier  experiments.  Since  this 
treatment had no effect on the outcome, the FCS was used later without inactivation. 
The contents of the dosing syringe (~7  ml) was distributed  to six membrane feeders. 
100 ~1 of the antigamete antibody in phosphate-buffered saline (PBS) was then introduced 
and  mixed with  the  mosquito feed material  (1-3  mg IgG/ml final  concentration).  The 
same volume of PBS was used as a control. Anopheles stephensi mosquitoes (Kasur strain) 
were allowed to feed through the  parafilm  membrane for  I0 min.  The fully engorged 
mosquitoes were held  at  26°C  for  7  d  and  their  midguts  examined  for oocysts. In all 
experiments,  at  least  10  mosquitoes  feeding  on  the  PBS  control  were  included.  The 
degree of transmission block was assessed as the mean percent reduction in the number 
of oocysts compared with the average in the controls in all experiments with that particular 
mAb. 
Production  of mAb.  BALB/c mice were immunized with freshly isolated P. falciparum 
macrogametes;  5-10  x  10  6  gametes  were  injected  intraperitoneally  together  with  l0 s 
lyophilized BordeteUa pertussis  (National Institute of Health and Environmental Hygiene, 
Bilthoven,  The  Netherlands).  After  6  too,  5  x  106  macrogametes  were  given  as  an 
intravenous booster 3 d before the fusion. Spleen cells of the immunized mice were fused 
with myeloma cells of the line P3/X63-Ag 8.653 (17).  The fusion protocol was derived 
from the methods reviewed by Fazekas de St. Groth and Scheidegger (18). A considerable 
increase in the number of stable hybridomas was achieved by using thymocyte-conditioned 
HAT (hypoxanthine,  aminopterin,  thymidine)  medium  (19).  Between  days  10 and  14, 
hybridoma supernates were collected for antibody testing. At the same time three of the 
four  culture  trays  were  frozen  according  to  the  procedure  of  De  Ley  et  al.  (20). 
Hybridomas were selected that satisfied four tests. 
The supernates were screened for antibodies specific for P. falciparum macrogametes 
in an immunofluorescent antibody assay (IF assay) with air-dried macrogametes as antigen. 
The hybridomas with the highest Ig production were selected in a direct enzyme-linked 
immunosorbent  assay  (ELISA) using  rabbit  anti-mouse  Ig (see  below) as  immobilized 
antibody. The reactivity with surface components of live macrogametes was tested  in a 
suspension IF assay using I 0 ~ freshly isolated macrogametes and 50 #1 hybridoma super- 
natant. Hybridomas were further selected on the basis of their reactivity with macrogamete 
proteins on Western blots.  Technical details of Western blotting and immune detection 
are  discussed  below.  Ascites  fluid  was  produced  in  Pristan-primed  BALB/c  mice  by 
injecting 1-10 X 106 twicely cloned hybridoma cells intraperitoneally. 
Usually,  mAb were  used  after  50%  ammonium  sulfate  precipitation  of ascites  fluid 
followed by solubilization and extensive dialysis against PBS.  For special purposes, how- 
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liquid chromatography (FPLC) (Pharmacia,  Inc., Piscataway,  N  J). Separation conditions 
were as described by Hill et al. (24). 
Antisera.  Rabbit anti-mouse IgG (RAM IgG) was produced by injecting New Zealand 
White rabbits with 2 mg protein A-purified BALB/c IgG in complete Freund's adjuvant 
given  intramuscularly.  5-wk  later,  200  ~g  IgG in  incomplete  Freund's  adjuvant  was 
administered by the same route. The concentration of specific antibodies was checked in 
a  double diffusion assay  (25).  RAM IgG was used for most purposes as an ammonium 
sulfate-purified fraction. In specific experiments, however, affinity purification was nec- 
essary.  Protein  A-Sepharose-purified  BALB/c  IgG  was  therefore  coupled  to  CNBr- 
activated Sepharose Cl-4B (Pharmacia, Inc.) according to standard methods (5 mg IgG/ 
ml activated Sepharose). Ammonium sulfate-purified IgG in PBS was allowed to bind in 
PBS, and the bound material was eluted using 1 M acetic acid. 
Rabbit antimacrogamete serum was produced by injecting a New Zealand White rabbit 
(rabbit 1771) intraperitoneally with 2 doses,  5 wk apart, of 10 ×  106 to 20 ×  106 purified 
macrogametes in PBS, and an intravenous third dose, 3 wk later, of 5 ×  106 macrogametes. 
Purification  of Different  Parasitic  Stages of P. falciparum.  Macrogametes and gameto- 
cytes: After 30-45  rain  incubation  in  FCS at  25°C,  the parasite  suspension  contained 
microgametes, macrogametes/zygotes, immature gametocytes, asexual stages,  and unin- 
fected red cells. This suspension was layered on top of a triple layer Nycodenz (Nijegaard, 
Oslo,  Norway) gradient.  A  27.6%  (wt/vol) Nycodenz stock solution was prepared in  5 
mM  Tris-HCI  (pH  7.5)  containing  3  mM  KCI  and  0.3  mM  CaNa2-EDTA.  Several 
Nycodenz concentrations were prepared by dilution of the stock solution with  medium 
199 (M199),  adjusted to pH 7.8 with  0.3 M Tris-HC1  ofpH 8.0.  The gradient consisted 
of 7-ml layers  of 16,  11, and 6%  Nycodenz (modified from Vermeulen et al. [16]). The 
gradient was centrifuged for 30 rain  at  7,000 gm,x at  4°C in  a  Sorvall  Superspeed  5B 
centrifuge adapted  with  a  slow-rate  accelerator  (DuPont  Instruments,  Newtown,  CT) 
using an  Hb-4 swing out rotor. The 6%  fraction contained free microgametes, red cell 
ghosts,  pigment,  and  unidentified  debris;  the  pellet  contained  asexual  parasites  and 
uninfected  red  cells.  Both  these  fractions were  discarded.  The  macrogametes/zygotes 
were harvested from the 6-11% interface; the nonactivated gametocytes were found at 
the  11-16%  layer.  Cells  were washed once with  50  ml  of M199 and  used  for further 
studies.  The macrogamete/zygote suspensions  were of high purity, containing only some 
contaminating red  blood cells. In  the  immature  gametocyte fractions,  however,  some 
asexual parasites were found. 
Schizont-enriched fractions were obtained from 4-d-old suspension cultures by centrif- 
ugation on an 18% Nycodenz cushion, under the same centrifugation conditions as above. 
Radiotabeling  and Solubilization  of Macrogamete/Zygote Proteins.  20 X 106 to 50 X 106 
purified macrogametes were surface labeled using the lactoperoxidase/glucose oxidase- 
catalyzed 125I iodination (21,  22).  Biosynthetic labeling was performed by incubating 107 
purified macro~ametes/zygotes in  2 ml methionine-free RPMI  1640/10% FCS (pH 7.8) 
and  200  #Ci  [~SS]methionine  (sp  act,  1,200  mCi/mmol;  Amersham  Corp.,  Arlington 
Heights, IL) up to 4 h at room temperature.  Radiolabeled proteins were solubilized  in 25 
mM Tris (pH  8.0)  plus 0.5%  Triton X-100 or Nonidet P-40 (NP-40) (Sigma  Chemical 
Co.,  St.  Louis,  MO),  pH  8.0  with  1 mM  phenylmethylsulfonyl fluoride (PMSF)  (stock 
solution, 100 mM PMSF in 2-propanol) (23) and tested for immunoreactivity as described 
below. 
lmmunoprecipitation  of Radiolabeled  Antigens.  Immune reactions with soluble,  radiola- 
beled  antigens were  carried out  in  two ways.  (a)  Indirect immunoprecipitation:  10  ~l 
ammonium sulfate-purified mAb was added to 50-100 ~1 antigen solution and incubated 
for 2 h at room temperature.  100 ~l protein A-Sepharose was added as a 50% suspension 
in  25 mM Tris/0.5%  Triton  X-I00/0.5  M NaCl,  pH  8.0 and  incubated for 30 rain  at 
room temperature. Antigen was released from the beads in 50 ~l sodium dodecyl sulfate 
(SDS) sample buffer (0.062 M Tris-HC1, pH 6.8/2.5% SDS), heated for 3 rain over boiling 
water, and analyzed on SDS-polyacrylamide gel electrophoresis (PAGE).  For those mAb 
that did not react with protein A, 50 ug RAM IgG was added and incubated for 30 min 
at room temperature before the protein A-Sepharose treatment.  (b) Solid phase immu- VERMEULEN  ET  AL.  1463 
noassay: Ammonium sulfate-purified mAb IgG was coated to polyvinylchloride  microtiter 
plates as described by Tamura et al. (26) at a concentration of 20-100 #g/ml in PBS. The 
plates were washed with PBS and saturated with 3% bovine serum albumin (BSA) (fraction 
V; Sigma Chemical Co.) in PBS by incubation for 1 h at 37°C. Radiolabeled antigen was 
diluted to 0.1% NP-40 with 25 mM Tris/0.5 M NaCl, pH 8.0. Up to l0  p cpm were added 
to each well and incubated for 3 h at 37 °C or 18 h at 4 o  C. Plates were washed extensively 
with  PBS/0.05%  NP-40.  Bound protein was eluted from the plates using SDS  sample 
buffer and analyzed by SDS-PAGE and autoradiography. 
SDS-PAGE and Autoradiography.  SDS-PAGE was performed using the Laemmli buffer 
system (27) and gradient gels of 4-20% acrylamide (2.5% crosslinking). Electrophoresis 
was carried out at 25 mA constant current (V.,ax =  250 V).  Gels were either dried for 
autoradiograpby or  enhanced  using  1  M  sodium  salicylate (28)  or  Enlightning  (New 
England  Nuclear,  Dreieich,  Federal  Republic  of Germany) and  fluorographed  using 
Kodak XAR-5 film. 
Western Blotting  and  Immunodetection.  50  ×  106  to  70  x  106  macrogametes  were 
solubilized in  200-300 ttl SDS sample buffer, without the addition of reducing agents 
such as dithiothreitol (DTT) or 2-mercaptoethanol. SDS-PAGE was carried out as de- 
scribed above. Immediately after electrophoretic separation, the slab gel was incubated 
for 30 min in buffer (0.010 M Tris/0.079 M glycine, pH 8.3). Proteins were transferred 
electrophoretically to nitrocellulose paper (0.45 #m; Schleicher and Schuell, Inc., Keene, 
NH)  at  10  V/cm  (29).  For immunodetection  (30),  nitrocellulose strips  (3  mm)  were 
pretreated with 3% BSA in PBS for 1 h at room temperature, and incubated for 3 b with 
either 50-fold diluted hybridoma supernatants  or purified IgG (1000×  diluted).  After 
•  "  "  125  extensive washing with PBS/0.05% Tween-20, the strips were incubated m dduted  I- 
protein  A  or  ~25I-rabbit anti-mouse-affinity-purified IgG  (0.1  ~Ci/strip).  Strips  were 
washed, dried, and autoradiographed against Kodak XAR-5 film using screen anaplifica- 
tion. Proteins blotted onto nitrocellulose paper were visualized using India ink according 
to the procedure described by Hancock and Tsang (31). All protein concentrations were 
determined according to the Lowry method (32) using BSA and pooled human serum as 
standard. 
Results 
Macrogamete Surface Proteins.  Surface labeling of macrogametes resulted in a 
number of ~25I-labeled bands after separation on SDS-PAGE. The electrophoretic 
mobility of some proteins was different in the presence or absence of reducing 
agents like DTT.  In  Fig.  1 a, a  typical labeling pattern  is shown.  Usually, four 
major  polypeptides  could  be  detected.  Lane  1  contains  these  total  labeled 
polypeptides in nonreduced state (Mr 230, 48/45, 43, and 10 K). Under reducing 
conditions  the  above proteins demonstrated  an M,  of 250,  58,  47,  and  10  K, 
respectively (Fig.  1 a, lane 2). The doublet at Mr 48/45 K did not separate under 
reducing conditions but migrated as one band at 58 K (see also lanes 5-8). Minor 
bands were seen at M,- 33,  25, and  16 K  (Mr under nonreducing conditions will 
be used in referring to the various proteins), mAb 32F1, 32F3, ~nd 32F5 reacted 
with  the Mr 48/45  K  doublet (Fig.  1 a,  lanes  3-8).  32F1  coprecipitated the Mr 
230  K  protein  (Fig.  1 a,  lanes  3  and  4).  Fig.  1 b  shows  the  ~25I-labeled  target 
proteins in the reduced state, mAb 28F1  reacted only with the Mr 230 K protein 
(250 K, Fig. 1 b, lane 1). mAb IIC5-B10 (gift from Dr. R. Carter)also precipitated 
the M~ 48/45  K proteins (58 K, Fig.  1 b, lane 2). The reaction of the polyvalent 
rabbit serum (1771) is shown in Fig.  1 b, lane 3. 
lmmunodetection  on  Western Blots.  Immunoblotting  experiments using  poly- 
clonal as well as monoclonal antibodies showed a somewhat different result (Fig. 
2). Polyclonal rabbit serum (Fig. 2, lane  1) did not bind to the Mr 230 K protein. 1464  ANTIGENS  EXPRESSED ON  MIDGUT STAGES  OF  P.  FALCIPARUM 
F~C,  URE  1.  (a) SDS-PAGE of I2sl surface-labeled proteins  of P. falciparum  macrogametes 
precipitated  by different  mAb. (Lane 1) Total labeled proteins under nonreducing conditions 
(NR). (2) Same as lane 1, but reduced.  (3) lmmunoprecipitated  by mAb 32F1 (NR). (4) Same 
as lane 3, but reduced. (5) Immunoprecipitated  by 32F3 (NR). (6) Same as lane 5, but reduced. 
(7) Immunoprecipitated  by 32F5 (NR); arrows indicate the Mr 48/45 K doublet. (8) Same as 
lane 7,  but reduced.  (9)  PBS control.  (b) SDS-PAGE of az~I surface-labeled proteins  of P. 
falciparum macrogametes precipitated  by mAb and polyclonal rabbit serum. (Lane 1) Immu- 
noprecipitated  by mAb 28F1. (2) Immunoprecipitated  by mAb IIC5-B10 (gift from Dr. R. 
Carter;  see also Ref. 9).  (3)  hnmunoprecipitated  by rabbit  serum  1771. (4)Total  labeled 
proteins.  Arrows  indicate  the  apparent  molecular  weight of the  relevant  proteins  (under 
reducing conditions). 
On the other hand, the same serum reacted prominently with an Mr 25 K protein 
that was not precipitated after surface iodination,  mAb that reacted with the  25 
K  protein  were  selected  by  immunoblotting  (Fig.  2,  lanes  3,  6,  7,  and  10). 
Similarly,  it  was  possible  to  select  mAb  reacting  with  an Mr  10  K  protein  that 
also recognized a  45  K  protein (Fig.  2, lane 4, 8, and 9). 
Transmission  Blocking  Assays.  Seven  transmission  blocking  and  eight  non- 
blocking antimacrogamete antibodies  were  identified  (Table I).  The  molecular 
weights  of the  proteins  of macrogamete/zygotes  recognized  by  the  mAb  and 
polyclonal  rabbit  serum  are  also  included  as a  reference.  Table  II gives  infor- 
mation on the potency of the different blocking antibodies, mAb 32F3,  the most 
powerful inhibitor of oocyst development, blocked transmission totally in all  11 
experiments,  involving  173  mosquitoes.  Among  the  controls,  the  mean  oocyst 
number  per  dissected  mosquito  was  24.  The  weakest  among the  blockers  was 
32F61,  which  reduced oocyst numbers by 74%  in  53  mosquitoes in four exper- 
iments.  The  mean  oocyst count  in  control  mosquitoes  was  16.  The  remaining 
five  blocking  antibodies  inhibited  oocyst  formation  >95%  in  experiments  in 
which the lowest mean oocyst number in control mosquitoes was  14. 
To discover whether the blocking action  of one mAb could be potentiated by 
mixing with  another,  mAb were  used  in  dilutions  that  on  their  own could  not 
totally  inhibit  transmission.  In  two experiments,  mAb  32FI  (nonblocker,  anti- 
230 and -48/45  K Mr proteins) was combined with  32F3  (blocker, anti-48/45  K 
M,- proteins).  Table  II1 shows  the  results  of the  blocking activity of the  combi- VERMEULEN  ET  AL.  1465 
FIGURE 2.  Western  blotting and  immunodetection of P. falciparum  macrogamete proteins 
(nonreduced).  The following antibody preparations were used: (Lane  1) Rabbit serum  1771. 
(2)  mAb 32F3.  (3)  32F61.  (4)  32F62.  (5)  PBS control. (6)  32F71.  (7)  32F72.  (8)  32F63.  (9) 
32F84. (10) 32F81. 
nations as  well as  the  individual, diluted FPLC-purified mAb.  The  results of 
transmission blockade using ammonium sulfate-purified mAb were similar (data 
not shown). 32F3,  which blocks totally at the normal concentration of 1-3  mg 
protein/ml, was unable to block at both 20-fold and 40-fold dilutions. In the first 
experiment a  1:20 dilution of 32F3 combined with 32F1 (nonblocker) increased 
the inhibition from 63 to 97% and, in the second experiment, from 74 to 85%. 
32F3 (dilution, 1:40) and 32F81 (1 : 10), when used individually, reduced oocyst 
formation by 36 and 89%, respectively. However, in the same experiment but 
in which the two mAb were mixed, the inhibition in the number of oocysts was 
increased to 98%.  In the second experiment the combination resulted in 94% 
oocyst reduction. Combinations of nonblocking mAb recognizing proteins of the 1466  ANTIGENS  EXPRESSED  ON  MIDGUT  STAGES  OF  P.  FALCIPARUM 
TABLE  I 
Action of a Selected Number of  Monoclonal and Polyclonal Antibodies 
Directed Against P. falciparum Macrogametes/Zygotes 
Molecular weight of target proteins 
230K  48/45K  45/10K  25K 
Transmission-blocking 
antibodies 
7FI1 
29F432  +  + 
32F3  + 
32F5  + 
32F61 
32F81 
1771"  +  + 
+ 
+ 
+ 
+ 
Nonblocking antibodies  7F3 
28F1 
32F1 
32F62 
32F63 
32F71 
32F72 
32F84 
+  + 
+ 
+  + 
* Rabbit polyclonal antibody. 
+ 
+ 
TABLE  II 
Degree of Transmission Block by Monoclonal and Polyclonal 
Antibodies Directed Against P. falciparum Macrogametes/Zygotes 
Mean percent reduc-  Total No. of test  Mean oocysts in 
Antibody  tion in oocysts corn-  mosquitoes dis-  control mosqui- 
pared with control  sected  toes 
7F11  97 (3)  79  17 
29F432  97 (2)  25  21 
32F3  100 (11)  173  24 
32F5  95 (5)  103  14 
32F61  74 (4)  53  16 
32F81  95 (6)  74  18 
1771"  99 (4)  76  19 
The number in parentheses indicates the number of experiments carried 
out with each antibody. 
* Rabbit polyclonal antibody. 
same  molecular  weight  or  different  molecular  weights  had  no  effect  on  the 
transmission when compared with controls (data not shown). 
Biosynthesis  of the M, 25 K  Protein.  To investigate  whether and,  if so,  when 
the Mr  25  K  protein  was de  novo synthesized,  freshly  purified  macrogametes 
were incubated in methionine-free  RPMI  1640 supplemented with ['~'~S]methio- 
nine.  The proteins labeled during 3  h  of incubation at 25°C are shown in  Fig. 
3, which shows a dominant band at M, ~25  K. This protein could be solubilized 
almost completely using 25  mM Tris/0.5%  Triton  X-100,  pH 8.0 (Fig.  4).  Fig. 
4, lane 2 contains the total protein labeled in 3 h; the Triton-solubilized fraction 
is shown in lane 3 and the residual proteins in the pellet after Triton extraction VERMEULEN  ET  AL.  1467 
TABLE III 
Transmission Blocking Activity of Dilutions of FPLC-purified mAb and their Combinations 
mAb: ..............  32F1  32F3  32F1 +  32F3  32F3  32F81  32]73 + 32F81 
Transmission  blocking 
(+/-)  ..............  -  +  -  +  +  +  +  + 
Dilution: ...........  1:10  1:20  1:10  1:20  1:40  1:10  1:40  1:10 
hlfectivity  rate*  Exp.  1  18/19  16/23  3/15  22/24  5/9  3/14 
Exp. 2  6/7  4/'8  5/7  9/' 10  5/' 11  8/'9 
Mean oocyst per mosquito  Exp.  1  11.4  4.2  0.4  7.3  1.3  0.2 
Exp. 2  46  11,8  6.9  15.9  8.5  2,7 
Mean percent reduction in  Exp.  1  0  63  97  36  89  98 
oocysts compared with  Exp. 2  0  74  85  65  82  94 
control 
* Rlfectivity rate: number of positive mosquitoes  per number dissected. 
FIGURE 3.  Nonreduced SDS-PAGE of [~sS]labeled proteins synthesized by purified P.falcip- 
arum macrogametes/zygotes up to 3 h after isolation. (Lane 1) After  15 min of labeling. (2) 
30 rain. (3) 60 min. (4) 90 rain. (5) 120 rain. (6) 180 min. 
in  lane  1.  Fig.  4,  lane  4  shows  that  the prominent band  at Mr  25  K  is  indeed 
precipitated by 32F61. 
Similar results were obtained with the transmission blocking mAb 32F81  and 
7F11 as well as the nonblockers 32F71 and 32F72 (see also Table I). Gametocytes 
synthesized  the Mr  25  K  protein  at  a  very low  but  detectable  level.  Although 
[35S]methionine  labeling  appeared  too  weak  to  immunoprecipitate  detectable 
quantities, the presence of the Mr 25 K protein in gametocytes was demonstrated 
on  Western  blots.  To  avoid  any  contamination  with  macrogamete  proteins, 
gametocytes were  harvested  in  the  presence  of  1  mg/ml  emetine/HC1,  which 
blocks protein  synthesis  irreversibly.  Equal  numbers  of both  gametocytes and 
macrogametes were applied to SDS-PAGE. A similar number of asexual parasites 
were  also  included  for  comparison.  The  proteins  were  separated  and  blotted 
onto nitrocellulose paper. The blots were screened for reaction with 32F61  (Fig. 
5A), with a  combination of 32F61  and 32F3 (Fig. 5B)and of 32F71  and 32F63 
(Fig. 5 C).  Whereas the intensity of the reaction to the Mr 45 K protein was equal 1468  ANTIGENS EXPRESSED ON  MIDGUT STAGES  OF  P.  FALCIPARUM 
FIGURE 4.  Nonreduced  SDS-PAGE of ~SS-labeled macrogamete/zygote  proteins solubilized 
in Triton  X-100 and precipitated  by mAb  32F61. (Lane  1)  Nonsolubilized proteins  after 
Triton extraction. (2) Total labeled proteins before extraction. (3) Triton-soluble fraction. (4) 
Mr 25 K protein precipitated by mAb 32F61. 
FIGURE 5.  Comparison of the presence of  Mr 48/45 and 25 K proteins in P. falciparum using 
Western blots of extracts from (1) asexual parasites, (2) gametocytes, (3) macrogametes. Blots 
were screened  using the  following mAb: (A) 32F61. (B) 32F61 plus 32F3. (C) 32F71 plus 
32F63. 
in both the sexual stages, the 25 K protein was more prominent in macrogametes 
than  in  gametocytes.  Asexual  stage  proteins  did  not  react  with  any  of  the 
antibodies used.  The Mr 25  K  protein is present in gametocytes, but is predom- 
inantly  synthesized  in  macrogametes/zygotes  and  is  a  target  of  transmission 
blockade of extracellularly present mAb. This suggested that, in the midgut, the 
M,  25  K  protein  is  expressed  later  on  the  surface  of the  stages,  during  the 
development from zygote to ookinete.  This was tested by surface immunofluo- VERMEULEN ET  AL.  1469 
rescence of midgut stages using different mAb. These developmental stages were 
obtained from mosquito midguts 24 h  after the infective feed. They were easily 
identified,  since gametocytes, asexual  blood forms, and noninfected red  blood 
cells had already been digested at that time. Fig. 6 shows the fluorescence of the 
three undigested forms using mAb 32F71.  Fig. 6a shows the fluorescence of an 
undeveloped macrogamete/zygote; Fig. 6b shows the intermediate stage of the 
developing  ookinete  (a  so-called  retort  cell);  in  Fig.  6c  the  ookinete  is  fully 
mature.  The  mAb  reacting  against  the  surface  components  of  these  stages 
precipitate only the Mr 25 K protein. 
Transmission Blocking Action ofmAb.  To investigate the effect of mAb on the 
development of ookinetes, mosquitoes were allowed to feed on mature gameto- 
cyte cultures to which blocking mAb 32F3 or 32F81  were added.  Some of the 
mosquitoes were dissected 24 h later, their midguts homogenized, and ookinetes 
counted in  a  hemocytometer. The  remainder  was  held at  26°C  for  1 wk and 
oocyst numbers determined. The data in Table IV show that the mode of action 
of the two mAb is different. 32F3 drastically blocks ookinete formation. 32F81, 
FIGURE 6.  Surface  immunofluorescence of different stages isolated from mosquito midguts 
24 h after the feeding with fertile P. falciparum gametocytes. All stages were incubated "live" 
with mAb 32F71 (anti-Mr 25 K protein) and FlTC-labeled goat anti-mouse IgG. (A) Unde- 
veloped macrogametes/zygotes. (B) Intermediate "retort cell". (C) Mature ookinete. None of 
these stages showed any surface fluorescence with mAb 32F3 or 32F63. 
TABLE IV 
Influence of Transmission Blocking mAb on the Development of Ookinetes 
PBS  32F3  32F81 
Exp. 1  Retort cells plus  1,560  + 480  0.0  800 + 380 
ookinetes* 
Oocysts*  7.0 + 5.7  0.0  0.0 
Exp. 2  Retort cells  1,180 + 500  20 _+ 60  520 -+ 350 
Ookinetes  2,060 -+ 1,000  40 +- 80  1,260  -+ 420 
Oocysts  22 -+ 32  0.0  0.9 +- 2 
All  data  are  based on  10  dissected mosquitoes per  group,  except for  the 
ookinete/retort  cell counts in Exp. 1 (n = 5). 
* Mean number of cells per mosquito +- SE. 
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however,  interferes  at a  later  stage  before oocyst formation.  In  experiment  1 
retort cells and ookinetes were not separately counted. The apparent reduction 
in ookinete and retort cell numbers by 32F81 was not significant by Wilcoxon's 
test. 
Discussion 
Fertile gametocytes ingested by a  mosquito vector undergo  several develop- 
mental  changes in the insect's midgut before oocysts are formed.  The extracel- 
lular  gametes,  zygotes,  and  ookinetes  could  become  the  target  of antibodies 
taken up by the mosquito together with the sexual stages. Antigens on the sexual 
stages of P. falciparum  were identified  using mAb antibodies.  The  strength  of 
transmission  block  depends  on  two  factors,  the  concentration  of the  specific 
antibodies and the quality of the gametocytes involved. Although the concentra- 
tion of mAb was relatively high in the transmission blocking assays, the number 
of infectious gametocytes (-20,000/mm 3) was much higher than in normal field 
conditions (33).  The effect of combinations of antigamete  mAb was first dem- 
onstrated  by Rener et al.  (34) with avian  malaria.  Later they showed a  similar 
phenomenon in P.falciparum (I 3). In our system, although complete transmission 
inhibition  could be achieved by a  single mAb, combinations of mAb could also 
potentiate transmission block. 
Target Proteins.  The  SDS-PAGE  pattern  of surface-labeled  proteins  of P. 
falciparum NF54 macrogametes was similar to that described by Rener et al. (13) 
for a Brazilian isolate. Some minor differences were apparent, such as the intense 
labeling of 8 to 10 bands in Rener's system as compared with four (Mr 230, 48, 
45,  and  10  K)  in  ours.  This  is  probably  due  to  technical  differences  in  the 
isolation procedure and labeling conditions. Another factor that could influence 
the labeling result  is the dynamics of protein  expression on the surface of the 
macrogamete/zygote.  This  is  a  relatively  short-lived  intermediate  form,  the 
surface of which changes during the transition from the gametocyte to ookinete. 
We confirm the finding of Rener et al. (13) that some labeled proteins showed a 
difference in  migration  in SDS-PAGE under  reducing and nonreducing  condi- 
tions. 
mAb were selected on the basis of their binding to proteins of M, 230, 48/45, 
45/10,  and  25  K.  These  proteins  were  shown  to  be  present  already  in  the 
gametocyte stage, but were expressed on the surface of the parasite only later in 
development. 
M, 230 K Protein.  This protein could be labeled on the surface of the freshly 
emerged macrogamete. I t was precipitated by the polyclonal rabbit serum (1771) 
as well as by some mAb,  such as  IIC5-B10 (13),  32F1,  29F432,  and  7F3,  but 
always together with the smaller proteins of M,  48/45 K. Only one mAb (28F1) 
was  monospecific for  the  M,  230  K  protein.  These  results  suggest  that  these 
three proteins could possess a  common antigenic site and that  they are interre- 
lated.  This  relationship,  however, is still  very questionable.  It appears  that  the 
quantity of the M, 230  K protein  precipitated  relative to the quantity of lower 
M,  proteins  differs  fi'om  one  mAb  to  another.  IIC5-B10,  raised  against  the 
Brazilian isolate, bound equal amounts of high and low M, protein (in our NF54 
system). On the other hand,  32F1,  29F432, and  7F3 bound significantly more VERMEULEN ET  AL.  1471 
of the  lower M,.  proteins.  This  suggests  that  the  Mr  230  K  protein  probably 
coprecipitates in a  nonspecific way. Another observation favoring this explana- 
tion  is that,  in  the  immunoblotting  experiments,  a  positive reaction  to  the Mr 
230 K protein could never be detected using any of the above-mentioned mAb 
or the  polyclonai serum.  That  this  lack of positive immunoblotting  reaction  is 
not due to a low transfer efficiency of the Mr 230 K protein is shown by the fact 
that intense bands up to 400 K were demonstrated by staining the nitrocellulose 
blots with India ink. The importance of the Mr 230 K protein in the transmission 
blocking action of these mAb is also not clear, mAb 28F1  (monospecific for the 
Mr 230  K  protein)  exhibited  no transmission  blocking activity. The Mr 230  K 
protein was not detectable by IF assay on the surface of developing ookinetes. 
Using synchronized gametocyte cultures we have studied the biosynthesis of 
the  Mr  230,  48,  45,  25,  and  10  K  proteins.  Pulse  chase  experiments  clearly 
indicated that no precursor-product relationship exists between any of the above 
proteins (Vermeulen, Van Deursen, Ponnudurai, and Brakenhoff, manuscript in 
preparation).  These results corroborate the studies by Kumar and Carter (35). 
M, 48/45 K  Doublet.  The significance of these two proteins in the develop- 
ment of the zygote to the ookinete stage has become very clear,  mAb such as 
32F3  and  32F5,  binding  to  an  epitope  of these  proteins,  were  able  to  block 
oocyst formation effectively. The proteins are already present in the gametocyte 
but  are  later  expressed  on  the  surface  of the  newly  emerged  macrogamete. 
Similar to the Mr 230 K protein, this set of proteins could no longer be detected 
on the intermediate stage (retort cell) between zygote and ookinete. Because of 
the above and due to the  fact that  32F3  completely blocked the  formation  of 
retort cells/ookinetes, it appears that these proteins play a significant role in the 
process of fertilization by the microgamete. Using surface iodination, Carter and 
Kaushal (10) could not detect any protein of Mr >50 K on transforming zygotes 
ofP. gallinaceum.  These antigens were found unaltered in the extraceilular fluid. 
It is very likely that a similar situation exists in P. falciparum and that the Mr 48/ 
45 K proteins are shed during ookinete development. 
The biologically significant  epitopes of this set of proteins were not sensitive 
to the action of SDS, as was demonstrated by immune reaction on Western blots. 
These  epitopes,  however,  were  sensitive  to  reduction  by  DTT.  The  reduced 
proteins not only showed a difference in molecular weight, but the reactivity of 
these blotted (DTT-treated)  proteins was abolished (data not shown).  Blocking 
mAb as  well as  nonblockers did  not  bind  to  these  reduced  proteins  on  blots, 
suggesting  that  these  epitopes  have  a  conformational  nature.  Transmission 
blocking activity was increased  by the combination  of nonblocking mAb 32F1 
with  the  blocker  32F3.  Since  both  mAb  recognize  the  same  proteins,  the 
potentiation of the blocking activity could have occurred only if the epitopes are 
different.  Crossreactivity could not be detected between epitopes of a  blocker 
(32F3)  and  a  nonblocker  (32F1)  in  experiments  using an  immunoradiometric 
assay modified  from  Zavala  et  al.  (36).  These  experiments  also demonstrated 
that the target epitopes of the blocking mAb were not repeated (37). 
Mr 45/10 K Set.  This set of proteins could also be detected in the gametocyte 
stage, mAb against these two proteins (32F62, 32F63, and 32F84), selected using 
Western  blots,  also  showed  a  positive  immunofluorescence  on  live  gametes. 1472  ANTIGENS  EXPRESSED  ON  MIDGUT  STAGES  OF  P.  FALCIPARUM 
However, none of these mAb could precipitate any surface-iodinated  bands or 
block oocyst formation  in  the  mosquito.  The  significance  of these  proteins  is 
therefore  not  yet clear.  It was remarkable  that  a  considerable  number  of the 
hybridoma lines produced antibodies directed against  this  set of proteins,  sug- 
gesting that they are very immunogenic.  The Mr 10 K protein is predominantly 
present with respect to the Mr 45  K one.  From preliminary  experiments  using 
two-dimensional  PAGE it appeared that the Mr 45 K protein is identical to that 
reacting with mAb 32F3.  Reduction of this 45 K protein by DTT resulted also 
in a  shift in Mr in  SDS-PAGE to 58  K.  The epitope present on both the Mr 45 
and  10 K proteins was, however, not sensitive to reduction (results not shown). 
M, 25 K Protein.  This protein is already present in mature gametocytes. That 
this  was  not  due  to  contamination  with  proteins  synthesized  by gametes  was 
confirmed  by the  use  of emetine  treatment.  Emetine  blocks protein  synthesis 
irreversibly.  The  suspended animation  (SA) medium  of Carter  et al.  (3) could 
not be used for this purpose since it was impossible to prevent the activation of 
gametocytes  in  the  presence  of this  buffer.  Preliminary  experiments  further 
indicate that the Mr 25 K protein is already being synthesized in small quantities 
in early stages of gametocyte development. 
mAb  against  this  protein  were  selected  on  Western  blots  of macrogamete 
proteins. Some mAb directed against this protein were able to block transmission 
(7F11,  32F61, and  32F81).  Nonblocking mAb probably bind to another deter- 
minant  on  the  molecule.  This  was  recently  demonstrated  using  the  two-site 
immunoradiometric  assay  (37).  From  these  studies  it  also  appeared  that  the 
transmission  blocking  epitopes  on  the Mr  25  K  protein  are  monovalently  ex- 
pressed (37). 
Thus, besides the 48/45  K set, the 25 K protein also plays an important role 
in  the parasite  development.  Using surface immunofluorescence  with  mAb on 
live cells, we demonstrated  that this protein is hardly detectable on the surface 
of newly emerged macrogametes, but that it becomes progressively expressed on 
the surface of the macrogamete/zygote over a  period of 2 h.  This also implies 
that  this protein  is probably not involved in  the fertilization  process, but has a 
function after the formation of the ookinete. This was confirmed by the fact that 
the  presence  of mAb  32F81  in  the  mosquito  bloodmeal  did  not  significantly 
influence the number of retort cells/ookinetes formed. Although the antibodies 
were bound to the surface of the transforming  zygote from ~2 h after the feed, 
they obviously did not hamper the development of the ookinete significantly.  It 
is suggested that  the Mr 25  K  protein  acts as a  ligand  for the  receptor on  the 
mosquito midgut cell wall and is therefore important for the penetration of the 
ookinete. 
Although detectable by IF assay on the surface of macrogametes/zygotes, the 
M, 25  K protein was not iodinated, probably due to a  lack of tyrosine/histidine 
residues exposed.  Using  surface iodination  of P.  gallinaceum  transforming  zy- 
gotes,  Carter  and  Kaushal  (10) demonstrated  two proteins of Mr 26 and  28  K 
under reducing conditions. Nonreduced, these proteins had Mr of 31  and 34 K, 
respectively.  It is difficult to produce P. falciparum  ookinetes in  vitro  (Sinden 
and  Verhave, personal  communication).  We have therefore not attempted sur- 
face iodination of this stage. VERMEULEN ET  AL.  1473 
The similarity between P. falciparum and P. gallinaceum is striking with regard 
to  the  expression  of  surface  proteins  during  gametogenesis  and  subsequent 
development of ookinetes. Not only are the molecular weights of the proteins in 
the two parasite species very similar, but apparently also their function and fate. 
Perhaps this resemblance in protein expression is not coincidental but due to the 
close  relationship  between  avian  plasmodia  and  P. falciparum,  as  has  been 
suggested  both  on  morphological  criteria  and  genomic  organization  (38,  39). 
The polyclonal and monoclonal antibodies used in this study are now being used 
for screening P. falciparum  genomic/cDNA  libraries.  Based on the  results  de- 
scribed in  this  paper  it is our belief that  the Mr 48/45  and  25  K  proteins are 
good  candidates  for  a  future  transmission  blocking  vaccine.  Such  a  vaccine 
containing a combination of epitopes from both proteins will ensure the blocking 
of transmission  even when the transmission potential in the population is high. 
Summary 
Plasmodium falciparum  gametocytes contain  specific antigens,  some of which 
(Mr 230,000, 48,000, 45,000) are expressed on the surface of the newly emerged 
macrogamete.  A  different  antigen  (Mr  25,000)  surrounds  the  surface  of the 
ookinete and, although  present to some extent in the developing gametocyte, is 
synthesized  in  high  quantities  by the  macrogamete/zygote and  expressed pro- 
gressively  on  the  transforming  zygote  surface.  These  antigens  are  targets  of 
transmission  blocking  antibodies  that  are  effective at  two distinct  points  after 
gametogenesis:  fertilization  of the  macrogamete and  ookinete to oocyst devel- 
opment. 
The  antigens  involved  in  the  fertilization  blockade  are  the  Mr  48  and  45 
proteins,  which  are  expressed  on  the  macrogamete  surface.  The  Mr  230  K 
coprecipitating  protein  probably plays no part  in  transmission  block,  mAb  di- 
rected against the Mr 25 K ookinete surface protein blocked transmission without 
inhibiting ookinete formation, indicating that this protein has an important role 
in the transformation of ookinete into oocyst. A combination of mAb recognizing 
different epitopes on the same protein molecule acted synergistically in inhibiting 
oocyst formation.  Using a mixture of two blocking mAb reacting against the Mr 
48/45  and  25  K  proteins,  respectively,  an  additive  blocking  effect could  be 
demonstrated. 
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